Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches

Journal of Investigative Dermatology

Volumn 114, Issue 1, 2000, Pages 142-148

  Müller, Gabriele ^a   Müller, Anke ^a   Jonuleit, Helmut ^a   Steinbrink, Kerstin ^a   Szalma, Claudia ^a   Paragnik, Lydia ^a   Lingnau, Karen ^b   Schmidt, Edgar ^b   Knop, Jürgen ^a   Enk, Alexander H ^a,b  

^a Clinical Research   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

DC vaccines; Dendritic cell development; Fetal calf serum free culture conditions for DC; In vivo therapeutic DC approaches

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034128825     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00832.x     Document Type: Article

References (22)

1. Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465-472, 1996
2. Caux C, Dezutter Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261, 1992
3. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cels triggers production of high levels of interleukin-12 and enhances t cell stimulatory capacity: T-T help via APC activation, J Exp Med 184:747-752, 1996
4. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10-16, 1997
5. Celuzzi CM, Myordomo JI, Storkus WJ, Lotze MT, Falo LD Jr: Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 183:283-287, 1996
6. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Baestselier P, Urbain J, Leo O, Moser M: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184:1413-1424, 1996
7. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Maramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702, 1992
8. Ingulli E, Mondino A, Khoruts A, Jenkins MK: In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J Exp Med 185:2133-2141, 1997
9. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH: Proinflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under FCS-free conditions. Eur J Immunol 27:3135-3142, 1997
10. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Garcia-Prats MD, DeLeo AB, Lotze MT: Bone marrow-derived dendritic cells serve as potent adjuvants for peptide based antitumor vaccines. Stem Cells 15:94-103, 1997
11. Murphy KM, Heimberger AB, Loh DY: Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250:1720-1723, 1990
12. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317-322, 1996
13. Porgardor A, Gilboa E: Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182:260-265, 1995
14. Porgardor A, Snyder D, Gilboa E: Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918-2926, 1996
15. Romani N, Schuler G: The Immunologic Properties of Epidermal Langerhans Cells as a Part of the Dendritic Cell System Springer Semin, Immunopathol. 13 (3-4): 265-279, 1992
16. Romani N, Reider D, Heuer M, Ebner S, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods 196:137151, 1996
17. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/rnacrophage colony-stimulating factor plus interleukin 4 and downregulated by TNF-. J Exp Med 179:1109-1118, 1994
18. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use micropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389-400, 1995
19. Schuler G, Thurner B, Romani N: Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int Arch Allergy Immunol 112:317-333, 1997
20. Steinman RM: The dendritic cell system and ist role in immunogenicity. Annu Rev Immunol 9:271-296, 1991
21. Yamaguchi Y, Tsumura H, Miwa M, Inaba K: Contrasting effects of TBF-1 and TNF-on the development of dendritic cells from progenitors in the mouse bone marrow. Stem Cells 15:144-153, 1997
22. Zitvogel L, Conderc B, Mayordomo JI, Robbins PD, Lotze MT, Storkus WJ: IL-12 engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann N Y Acad Sci 795:284-294, 1996